Literature DB >> 26517564

How specific is CRISPR/Cas9 really?

Henriette O'Geen1, Abigail S Yu1, David J Segal2.   

Abstract

The specificity of RNA-guided nucleases has gathered considerable interest as they become broadly applied to basic research and therapeutic development. Reports of the simple generation of animal models and genome engineering of cells raised questions about targeting precision. Conflicting early reports led the field to believe that CRISPR/Cas9 system was promiscuous, leading to a variety of strategies for improving specificity and increasingly sensitive methods to detect off-target events. However, other studies have suggested that CRISPR/Cas9 is a highly specific genome-editing tool. This review will focus on deciphering and interpreting these seemingly opposing claims.
Copyright © 2015 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26517564      PMCID: PMC4684463          DOI: 10.1016/j.cbpa.2015.10.001

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  43 in total

1.  Double nicking by RNA-guided CRISPR Cas9 for enhanced genome editing specificity.

Authors:  F Ann Ran; Patrick D Hsu; Chie-Yu Lin; Jonathan S Gootenberg; Silvana Konermann; Alexandro E Trevino; David A Scott; Azusa Inoue; Shogo Matoba; Yi Zhang; Feng Zhang
Journal:  Cell       Date:  2013-08-29       Impact factor: 41.582

2.  Target specificity of the CRISPR-Cas9 system.

Authors:  Xuebing Wu; Andrea J Kriz; Phillip A Sharp
Journal:  Quant Biol       Date:  2014-06

3.  An unbiased genome-wide analysis of zinc-finger nuclease specificity.

Authors:  Richard Gabriel; Angelo Lombardo; Anne Arens; Jeffrey C Miller; Pietro Genovese; Christine Kaeppel; Ali Nowrouzi; Cynthia C Bartholomae; Jianbin Wang; Geoffrey Friedman; Michael C Holmes; Philip D Gregory; Hanno Glimm; Manfred Schmidt; Luigi Naldini; Christof von Kalle
Journal:  Nat Biotechnol       Date:  2011-08-07       Impact factor: 54.908

4.  Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells.

Authors:  Xuebing Wu; David A Scott; Andrea J Kriz; Anthony C Chiu; Patrick D Hsu; Daniel B Dadon; Albert W Cheng; Alexandro E Trevino; Silvana Konermann; Sidi Chen; Rudolf Jaenisch; Feng Zhang; Phillip A Sharp
Journal:  Nat Biotechnol       Date:  2014-04-20       Impact factor: 54.908

5.  Flexible guide-RNA design for CRISPR applications using Protospacer Workbench.

Authors:  Cameron Ross MacPherson; Artur Scherf
Journal:  Nat Biotechnol       Date:  2015-06-29       Impact factor: 54.908

6.  Dimeric CRISPR RNA-Guided FokI-dCas9 Nucleases Directed by Truncated gRNAs for Highly Specific Genome Editing.

Authors:  Nicolas Wyvekens; Ved V Topkar; Cyd Khayter; J Keith Joung; Shengdar Q Tsai
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

7.  CAS9 transcriptional activators for target specificity screening and paired nickases for cooperative genome engineering.

Authors:  Prashant Mali; John Aach; P Benjamin Stranges; Kevin M Esvelt; Mark Moosburner; Sriram Kosuri; Luhan Yang; George M Church
Journal:  Nat Biotechnol       Date:  2013-08-01       Impact factor: 54.908

8.  In vivo genome editing using Staphylococcus aureus Cas9.

Authors:  F Ann Ran; Le Cong; Winston X Yan; David A Scott; Jonathan S Gootenberg; Andrea J Kriz; Bernd Zetsche; Ophir Shalem; Xuebing Wu; Kira S Makarova; Eugene V Koonin; Phillip A Sharp; Feng Zhang
Journal:  Nature       Date:  2015-04-01       Impact factor: 49.962

9.  Improving CRISPR-Cas nuclease specificity using truncated guide RNAs.

Authors:  Yanfang Fu; Jeffry D Sander; Deepak Reyon; Vincent M Cascio; J Keith Joung
Journal:  Nat Biotechnol       Date:  2014-01-26       Impact factor: 54.908

10.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

View more
  37 in total

1.  Stepping toward therapeutic CRISPR.

Authors:  Keith T Gagnon; David R Corey
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-07       Impact factor: 11.205

2.  Mechanisms of improved specificity of engineered Cas9s revealed by single-molecule FRET analysis.

Authors:  Digvijay Singh; Yanbo Wang; John Mallon; Olivia Yang; Jingyi Fei; Anustup Poddar; Damon Ceylan; Scott Bailey; Taekjip Ha
Journal:  Nat Struct Mol Biol       Date:  2018-04-05       Impact factor: 15.369

Review 3.  Cornerstones of CRISPR-Cas in drug discovery and therapy.

Authors:  Christof Fellmann; Benjamin G Gowen; Pei-Chun Lin; Jennifer A Doudna; Jacob E Corn
Journal:  Nat Rev Drug Discov       Date:  2016-12-23       Impact factor: 84.694

Review 4.  Defining and improving the genome-wide specificities of CRISPR-Cas9 nucleases.

Authors:  Shengdar Q Tsai; J Keith Joung
Journal:  Nat Rev Genet       Date:  2016-05       Impact factor: 53.242

5.  Systematic in vitro profiling of off-target affinity, cleavage and efficiency for CRISPR enzymes.

Authors:  Liyang Zhang; H Tomas Rube; Christopher A Vakulskas; Mark A Behlke; Harmen J Bussemaker; Miles A Pufall
Journal:  Nucleic Acids Res       Date:  2020-05-21       Impact factor: 16.971

6.  TRH Action Is Impaired in Pituitaries of Male IGSF1-Deficient Mice.

Authors:  Marc-Olivier Turgeon; Tanya L Silander; Denica Doycheva; Xiao-Hui Liao; Marc Rigden; Luisina Ongaro; Xiang Zhou; Sjoerd D Joustra; Jan M Wit; Mike G Wade; Heike Heuer; Samuel Refetoff; Daniel J Bernard
Journal:  Endocrinology       Date:  2017-04-01       Impact factor: 4.736

7.  crisprSQL: a novel database platform for CRISPR/Cas off-target cleavage assays.

Authors:  Florian Störtz; Peter Minary
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

8.  Mutant Cas9-transcriptional activator activates HIV-1 in U1 cells in the presence and absence of LTR-specific guide RNAs.

Authors:  Veronica Kim; Brian M Mears; Bonita H Powell; Kenneth W Witwer
Journal:  Matters (Zur)       Date:  2017-01-12

Review 9.  CRISPR GENOME SURGERY IN THE RETINA IN LIGHT OF OFF-TARGETING.

Authors:  Galaxy Y Cho; Kellie A Schaefer; Alexander G Bassuk; Stephen H Tsang; Vinit B Mahajan
Journal:  Retina       Date:  2018-08       Impact factor: 4.256

Review 10.  Genome Engineering with TALE and CRISPR Systems in Neuroscience.

Authors:  Han B Lee; Brynn N Sundberg; Ashley N Sigafoos; Karl J Clark
Journal:  Front Genet       Date:  2016-04-06       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.